Doctors could soon be using a blood test as a minimally invasive monitoring tool for the early detection of uveal melanoma, Australian researchers say.

A team from the University of Queensland (UQ) has found a panel of six blood biomarkers that can differentiate uveal benign moles and melanomas, as well as whether the melanomas have metastasised.